TIAA CREF Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.34M | Sell |
|
|||||
|
2018
Q2 | $1.97M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $342K | Sell |
|
|||||
|
2016
Q4 | $351K | Sell |
|
|||||
|
2016
Q3 | $434 | Hold |
|
|||||
|
2016
Q2 | $451K | Buy |
|
|||||
|
2016
Q1 | $425K | Hold |
|
|||||
|
2015
Q4 | $550K | Sell |
|
|||||
|
2015
Q3 | $842K | Buy |
|
|||||
|
2015
Q2 | $811K | Buy |
|
|||||
|
2015
Q1 | $882K | Buy |
|
|||||
|
2014
Q4 | $843K | Sell |
|
|||||
|
2014
Q3 | $900K | Buy |
|
|||||
|
2014
Q2 | $974K | Buy |
|
|||||
|
2014
Q1 | $2.79M | Sell |
|
|||||
|
2013
Q4 | $1.3M | Sell |
|
|||||
|
2013
Q3 | $2.32M | Sell |
|
|||||
|
2013
Q2 | $2.48M | Buy |
|